ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Neutrophil Extracellular Traps"

  • Abstract Number: 573 • 2016 ACR/ARHP Annual Meeting

    Synovial Fibroblast-Neutrophil Interactions Promote Pathogenic Adaptive Immunity in Rheumatoid Arthritis

    Carmelo Carmona-Rivera1, Erica Moore2, Nithya Lingampalli3, Hannes Uchtenhagen4, Eddie James5, Kevin L. Bicker6, Heidi Wähämaa7, Victoria Hoffmann8, Anca I Catrina7, Paul Thompson9, Jane H. Buckner5, William Robinson10, David Fox11 and Mariana Kaplan2, 1Systemic Autoimmunity Branch/ NIAMS, National Institutes of Health, Bethesda, MD, 2Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Benaroya Research Institute at Virginia Mason, Seattle, WA, 6Middle Tennessee State University, Murfreesboro, TN, 7Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 8Division of Veterinary Resources, National Institutes of Health, Bethesda, MD, 9University of Massachusetts, Worcester, MA, 10Stanford University School of Medicine, Stanford, CA, 11Department of Medicine [Division of Rheumatology], University of Michigan, Ann Arbor, MI

    Background/Purpose:   Methods:   Results:   Conclusion:  
  • Abstract Number: 1006 • 2016 ACR/ARHP Annual Meeting

    Immune Complex-Mediated TLR8 Activation Shifts Neutrophils from Phagocytosis to Netosis through Furin-Dependent Shedding of Fcgriia

    Christian Lood1, Sabine Arve2, Laura Durcan2, Jeffrey Ledbetter2 and Keith B. Elkon1, 1Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Seattle, WA

    Background/Purpose:  Neutrophils, isolated from healthy individuals, were incubated with RNA-ICs and analyzed for phagocytosis and NETosis by flow cytometry and fluorimetry, respectively, in the presence…
  • Abstract Number: 1756 • 2016 ACR/ARHP Annual Meeting

    Novel Role of Rho Kinase in Neutrophil Netosis during UVB Induced-Skin Inflammation

    Ming-Lin Liu1,2, Meena Sharma2,3 and Victoria P. Werth4,5, 1Department of Dermatology,, Philadelphia V.A. Medical Center, Philadelphia, PA, 2Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 3Department of Dermatology, Philadelphia V.A. Medical Center, Philadelphia, PA, 4Dermatology, University of Pennsylvania, Philadelphia, PA, 5Philadelphia V.A. Medical Center, Philidelphia, PA

    Background/Purpose:  Skin inflammation appears in cutaneous or systemic lupus erythematosus. Ultraviolet B (UVB) is an important environmental trigger of skin inflammation in lupus. Mechanisms linking…
  • Abstract Number: 1962 • 2016 ACR/ARHP Annual Meeting

    Antiphospholipid Syndrome Neutrophils Are Characterized By Overexpression of P-Selectin Glycoprotein Ligand 1, a Potential Therapeutic Target

    Jason S Knight1, Patrick S. Coit1, He Meng1, Srilakshmi Yalavarthi1, Paul Renauer1, Robert C Grenn1, Levi F Mazza1, Hui Wang2, Daniel T Eitzman2 and Amr H Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI

    Background/Purpose:  Treatment of the thrombotic manifestations of antiphospholipid syndrome (APS) primarily focuses on inhibiting clotting pathways. In an effort to identify upstream inflammatory targets that…
  • Abstract Number: 2058 • 2016 ACR/ARHP Annual Meeting

    Ectonucleotidase-Mediated Protection of Lupus Mice from Exaggerated Immune Responses and Arterial Vasculopathy

    Jason S Knight1, Levi F Mazza1, Srilakshmi Yalavarthi1, Yogen Kanthi2 and David J Pinsky2, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI

    Background/Purpose: CD39 and CD73 are so-called ectonucleotidases, surface enzymes expressed by leukocytes and endothelial cells that jut into the extracellular space. There, they mediate the…
  • Abstract Number: 3017 • 2016 ACR/ARHP Annual Meeting

    Elevated Neutrophil Extracellular Trap Levels Correlate with Anti-CCP3-IgG and Anti-CCP3-IgA Levels in the Sputum of Individuals at-Risk for Future Rheumatoid Arthritis

    M. Kristen Demoruelle1, Monica Purmalek2, Heather Rothfuss3, Michael Weisman4, Lindsay Kelmenson1, Michael Mahler5, Jill M. Norris6, Brian Cherrington3, Mariana Kaplan2, V. Michael Holers1 and Kevin D. Deane1, 1Rheumatology Division, University of Colorado Denver, Aurora, CO, 2Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Zoology and Physiology, University of Wyoming, Laramie, WY, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5Research and Development, Inova Diagnostics, San Diego, CA, 6Epidemiology, Colorado School of Public Health, Aurora, CO

    Background/Purpose: The initial site of anti-citrullinated protein antibody (ACPA) generation in RA has been proposed to be a mucosal site. We have previously demonstrated ACPA…
  • Abstract Number: 1787 • 2015 ACR/ARHP Annual Meeting

    Innate Immunity, Arterial Inflammation and Vascular Stiffness in Patients with Systemic Lupus Erythematosus

    Monica Purmalek1, Simantini Sakhardande1, Yenealem Temesgen-Oyelakin2, Alice Fike3, Taufiq Salahuddin4, Balaji Natarajan4, Zerai Manna2, Elizabeth Joyal2, Sarfaraz Hasni2, Nehal N. Mehta4 and Mariana J. Kaplan1, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4NHLBI, National Institutes of Health, Bethesda, MD

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) show a striking increase in risk of atherosclerotic cardiovascular disease (CVD) not explained by Framingham risk, compared to…
  • Abstract Number: 2002 • 2015 ACR/ARHP Annual Meeting

    Dnase Treatment Protects Against DVT Formation in a Mouse Model of Antiphospholipid Syndrome

    He Meng1, Srilakshmi Yalavarthi2, Levi F. Mazza3, Megan A. Elfline1, Catherine E. Luke1, Peter K. Henke1 and Jason S. Knight2, 1University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose:  Antiphospholipid antibodies, especially those targeting beta-2-glycoprotein I (β2GPI), have been shown to amplify thrombosis in mice.  However, most published models have relied on endothelial…
  • Abstract Number: 2072 • 2015 ACR/ARHP Annual Meeting

    Mitochondrial Reactive Oxygen Species Modulate Autoimmunity in Systemic Lupus Erythematosus

    Luz P. Blanco1, Christian Lood2, Monica Purmalek3, Suk See DeRavin4, Carolyne K. Smith3, Carmelo Carmona-Rivera3, Harry Malech4, Jeffrey Ledbetter5, Keith B. Elkon6 and Mariana J. Kaplan1, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Internal Medicine, University of Washington, Seattle, WA, 3Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4NIAID/NIH, Bethesda, MD, 5University of Washington, Seattle, WA, 6Department of Medicine & Immunology, University of Washington, Seattle, WA

    Background/Purpose: Dysregulation in the formation of neutrophil extracellular traps (NETs) may contribute to modification and externalization of autoantigens and to organ damage in diverse autoimmune…
  • Abstract Number: 2073 • 2015 ACR/ARHP Annual Meeting

    Mitochondrial ROS Is a Novel Regulator of Sting-Mediated Type I IFN Production By Governing Extrusion of Oxidized Mitochondrial DNA upon Neutrophil Extracellular Trap Formation.

    Christian Lood1, Luz P. Blanco2, Monica Purmalek3, Carolyne K. Smith3, Carmelo Carmona-Rivera3, Jeffrey Ledbetter4, Mariana J. Kaplan2 and Keith B. Elkon5, 1Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 2Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4University of Washington, Seattle, WA, 5Division of Rheumatology, University of Washington, Seattle, WA

    Background/Purpose: Neutrophil extracellular trap generation (NETosis) is a reactive oxygen species (ROS)-dependent cell death pathway implicated in autoimmune disorders such as systemic lupus erythematosus (SLE).…
  • Abstract Number: 2121 • 2015 ACR/ARHP Annual Meeting

    Placentas of Lupus Pregnancies Are Characterized By Marked Inflammatory Changes Despite Good Disease Control

    Wendy Marder1, Jason S. Knight2, Mariana J. Kaplan3, Emily C. Somers4, Xu Zhang4, Alexander A. O'Dell5, Vasantha Padmanabhan4 and Richard W. Lieberman4, 1Div of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4University of Michigan, Ann Arbor, MI, 5Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose:   Systemic lupus erythematosus (SLE) is associated with increased risk of adverse pregnancy outcomes (APO), including preeclampsia and intrauterine growth restriction.  While significant placental…
  • Abstract Number: 2598 • 2015 ACR/ARHP Annual Meeting

    Neutrophil Extracellular Trap Levels Measured By Cell Free Nucleosome ELISA in Serum Are Highly Specific and Sensitive for Rheumatoid Arthritis

    Paul Hasler1, Stavros Giaglis1, Ulrich A. Walker2, Erik Deman1, Christoph Hemmeler1, Christina Ryser1, Samuel Kretzschmar1, Guenther Schaefer3, Juliane Franz1 and Sinuhe Hahn4, 1Rheumatology, Kantonsspital Aarau, Aarau, Switzerland, 2Rheumatology, University Hospital, Basel, Basel, Switzerland, 3Dept. of Biomedicine, Laboratory of Prenatal Medicine, University Hospital Basel, Basel, Switzerland, 4Dept. of Biomedicine, Laboratory for Prenatal Medicine, University Hospital Basel, Basel, Switzerland

    Background/Purpose: Rheumatoid factor (RF) or anti-citrullinated peptide antibody (ACPA) detection have limited clinical utility for the diagnosis of rheumatoid arthritis (RA), as the specificity and…
  • Abstract Number: 2709 • 2015 ACR/ARHP Annual Meeting

    Immediate  Release of Peripheral Neutrophil Myeloperoxidase and Elastase and Formation of Extracellular Traps to Cigarette Smoking in Rheumatoid Arthritis

    Juliane Franz1, Stavros Giaglis1,2, Guenther Schaefer3, Erik Deman1, Andreas Thueler4, Sinuhe Hahn2 and Paul Hasler1, 1Rheumatology, Kantonsspital Aarau, Aarau, Switzerland, 2Biomedicine, Laboratory of Prenatal Medicine, University Hospital Basel, Basel, Switzerland, 3Dept. of Biomedicine, Laboratory of Prenatal Medicine, University Hospital Basel, Basel, Switzerland, 4Rheumatology, Kantonsspital Baden, Baden, Switzerland

    Background/Purpose: Smoking represents an independent risk factor for rheumatoid arthritis (RA) (1). In response to infectious agents, neutrophil granulocytes can extrude their nuclear contents as…
  • Abstract Number: 3032 • 2015 ACR/ARHP Annual Meeting

    Role of Adenosine and Neutrophils in Inflammation Associated with Mutations in CECR1 Gene

    Kyawt W. Shwin1,2, Carmelo Carmona-Rivera3, Wanxia Tsai4, Chya-chia Richard Lee5,6, Elaine Novakovich7, Deborah L. Stone8, Amanda K. Ombrello8, Raphaela Goldbach-Mansky9, Massimo Gadina10, Daniel Kastner11, Ivona Aksentijevich12,13, Mariana J. Kaplan7 and Peter C. Grayson14,15, 1NIAMS, National Institutes of Health, BETHESDA, MD, 2Translational Autoinflammatory Diseases Section, National Institutes of Health, Bethesda, MD, 3Systemic Autoimmunity Branch/ NIAMS, National Institutes of Health, Bethesda, MD, 4Translational Immunology, Office of Science and Technology, National Institutes of Health, Bethesda, MD, 5National Cancer Institute, National Institutes of Health, Bethesda, MD, 6Laboratory of Pathology, NCI, National Institutes of Health, BETHESDA, MD, 7Systemic Autoimmunity Branch, NIAMS, National Institutes of Health, Bethesda, MD, 8National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 9Translational Autoinflammatory Diseases Section, NIAMS, NIH, Bethesda, MD, 10Translational Immunology, Office of Science and Technology, NIAMS, National Institutes of Health, Bethesda, MD, 11Inflammatory Disease Section, NHGRI, National Institutes of Health, Bethesda, MD, 12NIH/NHGRI, Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch, Bethesda, MD, 13Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 14National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 15NIAMS Systemic Autoimmunity Branch, National Institutes of Health, Bethesda, MD

    Background/Purpose: The phenotype of patients afflicted by deficiency of adenosine deaminase 2 (DADA2) due to mutations in CECR1encoding ADA2 protein shares many features with idiopathic…
  • Abstract Number: 205 • 2015 ACR/ARHP Annual Meeting

    Mode of Action of Therapeutic Anti-Citrullinated Protein Antibodies Revealed: Inflammation Reduction Due to Inhibition of Netosis

    Renato G.S. Chirivi1,2, Jos W.G. van Rosmalen1, Gonny Schmets1, Helmuth van Es2 and Jos M.H. Raats1,2, 1ModiQuest BV, Oss, Netherlands, 2Citryll BV, Nijmegen, Netherlands

    Background/Purpose: Neutrophils together with aberrant Neutrophil Extracellular Trap (NET) formation contribute to the induction and propagation of inflammation. A growing number of studies indicate that…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology